emicizumab
roche
['roche,(-broche),(-rocheter)']
flora peyvandi reported the adverse event profile of emicizumab vs ehl fviii for hemorrhagic and thrombotic events from the eudravigilance database. #hemophilia #ash22 
Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine & NHS. Opinions are my own.